-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Regenerx Biopharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Regenerx Biopharmaceuticals Inc Operating Income (Loss) for the quarter ending March 31, 2023 was -$305K, a 11.3% increase year-over-year.
- Regenerx Biopharmaceuticals Inc Operating Income (Loss) for the twelve months ending March 31, 2023 was -$1.36M, a 0.72% increase year-over-year.
- Regenerx Biopharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$1.4M, a 5.53% decline from 2021.
- Regenerx Biopharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$1.33M, a 2.62% decline from 2020.
- Regenerx Biopharmaceuticals Inc annual Operating Income (Loss) for 2020 was -$1.29M, a 2.59% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)